The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antimycobacterial Drugs-Global Market Insights and Sales Trends 2024
Synopsis
Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. avium-intracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively.
The global Antimycobacterial Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antimycobacterial Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Antimycobacterial Drugs market. Drugs Used for Tuberculosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drugs Used for Leprosy segment is estimated at % CAGR for the next seven-year period.
The hospital pharmacies segment dominated the antimycobacterial drugs market in 2017 due to easy availability of leprosy and tuberculosis medications in government hospitals. The segment is expected to continue to dominate the market from 2018 to 2025.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antimycobacterial Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antimycobacterial Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antimycobacterial Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antimycobacterial Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antimycobacterial Drugs covered in this report include Pfizer, Novartis, GlaxoSmithKline, Bayer, AstraZeneca, Sanofi, Merck, Lupin and Macleods Pharmaceuticals, etc.
The global Antimycobacterial Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
GlaxoSmithKline
Bayer
AstraZeneca
Sanofi
Merck
Lupin
Macleods Pharmaceuticals
Systopic Laboratories
Zydus Cadila
Global Antimycobacterial Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antimycobacterial Drugs market, Segment by Type:
Drugs Used for Tuberculosis
Drugs Used for Leprosy
Drugs Used for Atypical Mycobacteria
Global Antimycobacterial Drugs market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antimycobacterial Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antimycobacterial Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. avium-intracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively.
The global Antimycobacterial Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antimycobacterial Drugs in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Antimycobacterial Drugs market. Drugs Used for Tuberculosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drugs Used for Leprosy segment is estimated at % CAGR for the next seven-year period.
The hospital pharmacies segment dominated the antimycobacterial drugs market in 2017 due to easy availability of leprosy and tuberculosis medications in government hospitals. The segment is expected to continue to dominate the market from 2018 to 2025.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antimycobacterial Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antimycobacterial Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antimycobacterial Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antimycobacterial Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antimycobacterial Drugs covered in this report include Pfizer, Novartis, GlaxoSmithKline, Bayer, AstraZeneca, Sanofi, Merck, Lupin and Macleods Pharmaceuticals, etc.
The global Antimycobacterial Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Novartis
GlaxoSmithKline
Bayer
AstraZeneca
Sanofi
Merck
Lupin
Macleods Pharmaceuticals
Systopic Laboratories
Zydus Cadila
Global Antimycobacterial Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antimycobacterial Drugs market, Segment by Type:
Drugs Used for Tuberculosis
Drugs Used for Leprosy
Drugs Used for Atypical Mycobacteria
Global Antimycobacterial Drugs market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antimycobacterial Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antimycobacterial Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antimycobacterial Drugs Market Overview
1.1 Antimycobacterial Drugs Product Overview
1.2 Antimycobacterial Drugs Market Segment by Type
1.2.1 Drugs Used for Tuberculosis
1.2.2 Drugs Used for Leprosy
1.2.3 Drugs Used for Atypical Mycobacteria
1.3 Global Antimycobacterial Drugs Market Size by Type
1.3.1 Global Antimycobacterial Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Antimycobacterial Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antimycobacterial Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antimycobacterial Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antimycobacterial Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antimycobacterial Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antimycobacterial Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antimycobacterial Drugs Sales Breakdown by Type (2018-2023)
2 Global Antimycobacterial Drugs Market Competition by Company
2.1 Global Top Players by Antimycobacterial Drugs Sales (2018-2023)
2.2 Global Top Players by Antimycobacterial Drugs Revenue (2018-2023)
2.3 Global Top Players by Antimycobacterial Drugs Price (2018-2023)
2.4 Global Top Manufacturers Antimycobacterial Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antimycobacterial Drugs Market Competitive Situation and Trends
2.5.1 Antimycobacterial Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antimycobacterial Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antimycobacterial Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Antimycobacterial Drugs Market
2.8 Key Manufacturers Antimycobacterial Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antimycobacterial Drugs Status and Outlook by Region
3.1 Global Antimycobacterial Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antimycobacterial Drugs Historic Market Size by Region
3.2.1 Global Antimycobacterial Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Antimycobacterial Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Antimycobacterial Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antimycobacterial Drugs Forecasted Market Size by Region
3.3.1 Global Antimycobacterial Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Antimycobacterial Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Antimycobacterial Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antimycobacterial Drugs by Application
4.1 Antimycobacterial Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Antimycobacterial Drugs Market Size by Application
4.2.1 Global Antimycobacterial Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Antimycobacterial Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antimycobacterial Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antimycobacterial Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antimycobacterial Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antimycobacterial Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antimycobacterial Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antimycobacterial Drugs Sales Breakdown by Application (2018-2023)
5 North America Antimycobacterial Drugs by Country
5.1 North America Antimycobacterial Drugs Historic Market Size by Country
5.1.1 North America Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antimycobacterial Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Antimycobacterial Drugs Sales in Value by Country (2018-2023)
5.2 North America Antimycobacterial Drugs Forecasted Market Size by Country
5.2.1 North America Antimycobacterial Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Antimycobacterial Drugs Sales in Value by Country (2024-2029)
6 Europe Antimycobacterial Drugs by Country
6.1 Europe Antimycobacterial Drugs Historic Market Size by Country
6.1.1 Europe Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antimycobacterial Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Antimycobacterial Drugs Sales in Value by Country (2018-2023)
6.2 Europe Antimycobacterial Drugs Forecasted Market Size by Country
6.2.1 Europe Antimycobacterial Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Antimycobacterial Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Antimycobacterial Drugs by Region
7.1 Asia-Pacific Antimycobacterial Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antimycobacterial Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antimycobacterial Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antimycobacterial Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Antimycobacterial Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antimycobacterial Drugs Sales in Value by Region (2024-2029)
8 Latin America Antimycobacterial Drugs by Country
8.1 Latin America Antimycobacterial Drugs Historic Market Size by Country
8.1.1 Latin America Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antimycobacterial Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antimycobacterial Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Antimycobacterial Drugs Forecasted Market Size by Country
8.2.1 Latin America Antimycobacterial Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antimycobacterial Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Antimycobacterial Drugs by Country
9.1 Middle East and Africa Antimycobacterial Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Antimycobacterial Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antimycobacterial Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antimycobacterial Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antimycobacterial Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Antimycobacterial Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antimycobacterial Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Antimycobacterial Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Antimycobacterial Drugs Products Offered
10.2.5 Novartis Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Antimycobacterial Drugs Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Bayer
10.4.1 Bayer Company Information
10.4.2 Bayer Introduction and Business Overview
10.4.3 Bayer Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer Antimycobacterial Drugs Products Offered
10.4.5 Bayer Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AstraZeneca Antimycobacterial Drugs Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Sanofi
10.6.1 Sanofi Company Information
10.6.2 Sanofi Introduction and Business Overview
10.6.3 Sanofi Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sanofi Antimycobacterial Drugs Products Offered
10.6.5 Sanofi Recent Development
10.7 Merck
10.7.1 Merck Company Information
10.7.2 Merck Introduction and Business Overview
10.7.3 Merck Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Merck Antimycobacterial Drugs Products Offered
10.7.5 Merck Recent Development
10.8 Lupin
10.8.1 Lupin Company Information
10.8.2 Lupin Introduction and Business Overview
10.8.3 Lupin Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Lupin Antimycobacterial Drugs Products Offered
10.8.5 Lupin Recent Development
10.9 Macleods Pharmaceuticals
10.9.1 Macleods Pharmaceuticals Company Information
10.9.2 Macleods Pharmaceuticals Introduction and Business Overview
10.9.3 Macleods Pharmaceuticals Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Macleods Pharmaceuticals Antimycobacterial Drugs Products Offered
10.9.5 Macleods Pharmaceuticals Recent Development
10.10 Systopic Laboratories
10.10.1 Systopic Laboratories Company Information
10.10.2 Systopic Laboratories Introduction and Business Overview
10.10.3 Systopic Laboratories Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Systopic Laboratories Antimycobacterial Drugs Products Offered
10.10.5 Systopic Laboratories Recent Development
10.11 Zydus Cadila
10.11.1 Zydus Cadila Company Information
10.11.2 Zydus Cadila Introduction and Business Overview
10.11.3 Zydus Cadila Antimycobacterial Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Zydus Cadila Antimycobacterial Drugs Products Offered
10.11.5 Zydus Cadila Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antimycobacterial Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antimycobacterial Drugs Industrial Chain Analysis
11.4 Antimycobacterial Drugs Market Dynamics
11.4.1 Antimycobacterial Drugs Industry Trends
11.4.2 Antimycobacterial Drugs Market Drivers
11.4.3 Antimycobacterial Drugs Market Challenges
11.4.4 Antimycobacterial Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antimycobacterial Drugs Distributors
12.3 Antimycobacterial Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
